CPH.TO vs. UFPT
CPH.TO (Cipher Pharmaceuticals Inc.) and UFPT (UFP Technologies, Inc.) are both stocks. Both are in the Healthcare sector — CPH.TO in Drug Manufacturers - Specialty & Generic, UFPT in Medical Devices. Over the past 10 years, CPH.TO returned 9.46%/yr vs 27.58%/yr for UFPT. At a 0.05 correlation, their price movements are largely independent.
Performance
CPH.TO vs. UFPT - Performance Comparison
Loading charts...
Different Trading Currencies
CPH.TO is traded in CAD, while UFPT is traded in USD. To make them comparable, the UFPT values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CPH.TO achieves a 9.03% return, which is significantly lower than UFPT's 13.24% return. Over the past 10 years, CPH.TO has underperformed UFPT with an annualized return of 9.46%, while UFPT has yielded a comparatively higher 27.58% annualized return.
CPH.TO
- 1D
- 0.12%
- 1M
- 0.55%
- 6M
- 7.11%
- YTD
- 9.03%
- 1Y
- 33.17%
- 3Y*
- 63.60%
- 5Y*
- 58.14%
- 10Y*
- 9.46%
- ALL TIME*
- 7.34%
UFPT
- 1D
- 1.34%
- 1M
- 2.06%
- 6M
- -4.84%
- YTD
- 13.24%
- 1Y
- 9.97%
- 3Y*
- 10.52%
- 5Y*
- 34.40%
- 10Y*
- 27.58%
- ALL TIME*
- 26.02%
CPH.TO vs. UFPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPH.TO Cipher Pharmaceuticals Inc. | 9.03% | 5.17% | 158.48% | 44.27% | 116.95% | 90.32% | -38.00% | -12.28% | -65.10% | 0.00% |
UFPT UFP Technologies, Inc. | 13.24% | -13.34% | 54.16% | 42.46% | 78.42% | 50.70% | -8.30% | 58.34% | 17.14% | 1.84% |
Correlation
The correlation between CPH.TO and UFPT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Aug 16, 2006 | 0.05 |
Fundamentals
CPH.TO:
CA$416.93M
UFPT:
$1.90B
CPH.TO:
$1.19
UFPT:
$8.80
CPH.TO:
9.77
UFPT:
27.90
CPH.TO:
0.12
UFPT:
0.52
CPH.TO:
5.95
UFPT:
3.14
CPH.TO:
2.27
UFPT:
4.36
CPH.TO:
$50.92M
UFPT:
$608.85M
CPH.TO:
$37.95M
UFPT:
$172.62M
CPH.TO:
$25.12M
UFPT:
$111.39M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPH.TO vs. UFPT — Risk / Return Rank
CPH.TO
UFPT
CPH.TO vs. UFPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cipher Pharmaceuticals Inc. (CPH.TO) and UFP Technologies, Inc. (UFPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPH.TO | UFPT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +1.00 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.08 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 1.46 | 0.32 | +1.14 |
| Martin ratioReturn relative to average drawdown | 2.78 | 0.63 | +2.16 |
Loading charts...
Drawdowns
CPH.TO vs. UFPT - Drawdown Comparison
The maximum CPH.TO drawdown since its inception was -97.90%, which is greater than UFPT's maximum drawdown of -68.60%. Use the drawdown chart below to compare losses from any high point for CPH.TO and UFPT.
Loading charts...
Drawdown Indicators
| CPH.TO | UFPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.90% | -68.60% | -29.30% |
Max Drawdown (1Y)Largest decline over 1 year | -22.83% | -31.28% | +8.45% |
Max Drawdown (3Y)Largest decline over 3 years | -42.50% | -47.82% | +5.32% |
Max Drawdown (5Y)Largest decline over 5 years | -42.50% | -47.82% | +5.32% |
Max Drawdown (10Y)Largest decline over 10 years | -94.31% | -47.82% | -46.49% |
Current DrawdownCurrent decline from peak | -16.82% | -29.17% | +12.35% |
Average DrawdownAverage peak-to-trough decline | -64.04% | -18.70% | -45.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.95% | 15.96% | -4.01% |
Volatility
CPH.TO vs. UFPT - Volatility Comparison
The current volatility for Cipher Pharmaceuticals Inc. (CPH.TO) is 5.92%, while UFP Technologies, Inc. (UFPT) has a volatility of 15.88%. This indicates that CPH.TO experiences smaller price fluctuations and is considered to be less risky than UFPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPH.TO | UFPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.92% | 15.88% | -9.96% |
Volatility (6M)Calculated over the trailing 6-month period | 27.61% | 32.42% | -4.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.38% | 45.31% | -3.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.51% | 45.07% | +4.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.67% | 40.18% | +20.49% |
Dividends
CPH.TO vs. UFPT - Dividend Comparison
Neither CPH.TO nor UFPT has paid dividends to shareholders.
Financials
CPH.TO vs. UFPT - Financials Comparison
This section allows you to compare key financial metrics between Cipher Pharmaceuticals Inc. and UFP Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPH.TO vs. UFPT - Profitability Comparison
CPH.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.
UFPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, UFP Technologies, Inc. reported a gross profit of 44.36M and revenue of 154.20M. Therefore, the gross margin over that period was 28.8%.
CPH.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.
UFPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, UFP Technologies, Inc. reported an operating income of 23.37M and revenue of 154.20M, resulting in an operating margin of 15.2%.
CPH.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.
UFPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, UFP Technologies, Inc. reported a net income of 17.50M and revenue of 154.20M, resulting in a net margin of 11.4%.
Frequently Asked Questions
CPH.TO and UFPT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CPH.TO and UFPT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer